NLS Pharmaceutics and Kadimastem Advance Diabetes Treatment with FDA Submission
NLS Pharmaceutics ( (NLSP) ) has shared an update.
Nationwide Recall of Supplement Containing Drugs That Can Kill
Supplements are being recalled because they contain prescription diabetes drugs that could have fatal side effects.